MedPath

Effect of Duralabhadi Kwatha in the Management of Urinary tract infections w.s.r. to Pittaja Mutrakrichhra

Not Applicable
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2021/06/033983
Lead Sponsor
Principal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Both fresh and recurrent cases will be selected.

2)Patients who present with sign and symptoms of Pittaja Mutrakrichhra/UTI.

3)Patients willing for trial.

Exclusion Criteria

1)Patients not willing for trail.

2)Patients with chronic renal failure and diabetes mellitus will be excluded.

3)Patient with defects in voiding mechanism as incontinence of urine and atonic bladder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fulfillment of objective and subjective criteriaTimepoint: 3 weeks
Secondary Outcome Measures
NameTimeMethod
Change in clinical symptomsTimepoint: 3 weeks
© Copyright 2025. All Rights Reserved by MedPath